Fulgent Genetics Inc (FLGT)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2021 | 09-2021 | 06-2021 | 03-2021 | 12-2020 | |
| Sales | 251,671 | 227,868 | 153,616 | 359,429 | 294,978 |
| Cost of Goods | 62,134 | 43,466 | 35,858 | 74,075 | 51,772 |
| Gross Profit | 189,537 | 184,402 | 117,758 | 285,354 | 243,206 |
| Operating Expenses | 38,811 | 25,595 | 19,718 | 18,507 | 18,069 |
| Operating Income | 150,860 | 159,273 | 98,898 | 266,922 | 225,909 |
| Other Income | -35 | 496 | 4,338 | 282 | -1,031 |
| Pre-tax Income | 150,825 | 159,769 | 103,236 | 267,204 | 224,878 |
| Income Tax | 47,148 | 37,545 | 23,589 | 66,513 | 58,571 |
| Net Income Continuous | 103,677 | 122,224 | 79,647 | 200,691 | 166,307 |
| Minority Interests | -662 | -298 | -165 | N/A | N/A |
| Net Income | $104,339 | $122,522 | $79,812 | $200,691 | $166,307 |
| EPS Basic Total Ops | 3.42 | 4.13 | 2.74 | 6.96 | 7.27 |
| EPS Basic Continuous Ops | 3.40 | 4.12 | 2.73 | 6.96 | 7.27 |
| EPS Diluted Total Ops | 3.34 | 3.93 | 2.59 | 6.52 | 6.88 |
| EPS Diluted Continuous Ops | 3.32 | 3.92 | 2.58 | 6.52 | 6.87 |
| EBITDA(a) | $156,457 | $164,765 | $103,184 | $270,147 | $227,561 |